BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37676833)

  • 1. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.
    Wolfson EA; Schonberg MA; Eliassen AH; Bertrand KA; Shvetsov YB; Rosner BA; Palmer JR; LaCroix AZ; Chlebowski RT; Nelson RA; Ngo LH
    J Natl Cancer Inst; 2024 Jan; 116(1):81-96. PubMed ID: 37676833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for predicting both breast cancer risk and non-breast cancer death among women > 55 years old.
    Schonberg MA; Wolfson EA; Eliassen AH; Bertrand KA; Shvetsov YB; Rosner BA; Palmer JR; Ngo LH
    Breast Cancer Res; 2023 Jan; 25(1):8. PubMed ID: 36694222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.
    Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Hankinson SE; Marcantonio ER; Ngo LH
    Breast Cancer Res Treat; 2016 Dec; 160(3):547-562. PubMed ID: 27770283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
    Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a breast cancer risk prediction model developed for Black women.
    Boggs DA; Rosenberg L; Pencina MJ; Adams-Campbell LL; Palmer JR
    J Natl Cancer Inst; 2013 Mar; 105(5):361-7. PubMed ID: 23411594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.
    Boggs DA; Rosenberg L; Adams-Campbell LL; Palmer JR
    J Clin Oncol; 2015 Mar; 33(9):1038-44. PubMed ID: 25624428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of the Gail model in the Black Women's Health Study.
    Adams-Campbell LL; Makambi KH; Palmer JR; Rosenberg L
    Breast J; 2007; 13(4):332-6. PubMed ID: 17593036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
    Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
    JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
    Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
    J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy and breast cancer.
    Santen RJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():52-61. PubMed ID: 23871991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
    Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.
    Wang S; Ogundiran T; Ademola A; Olayiwola OA; Adeoye A; Sofoluwe A; Morhason-Bello I; Odedina S; Agwai I; Adebamowo C; Obajimi M; Ojengbede O; Olopade OI; Huo D
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):636-643. PubMed ID: 29678902
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
    Clift AK; Dodwell D; Lord S; Petrou S; Brady M; Collins GS; Hippisley-Cox J
    BMJ; 2023 May; 381():e073800. PubMed ID: 37164379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study.
    Nelson RA; Soto-Perez-de-Celis E; Chlebowski RT; Schonberg M; Mortimer J; Pan K; Hou L; Neuhouser ML; Reding KW; Saquib N; Wactawski-Wende J; Wolfson E; Sedrak MS; Kruper L
    J Natl Compr Canc Netw; 2023 Jun; 21(6):636-644.e13. PubMed ID: 37308127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
    Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
    Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating breast cancer risk projections for Hispanic women.
    Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
    Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting individualized absolute invasive breast cancer risk in African American women.
    Gail MH; Costantino JP; Pee D; Bondy M; Newman L; Selvan M; Anderson GL; Malone KE; Marchbanks PA; McCaskill-Stevens W; Norman SA; Simon MS; Spirtas R; Ursin G; Bernstein L
    J Natl Cancer Inst; 2007 Dec; 99(23):1782-92. PubMed ID: 18042936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
    Li K; Anderson G; Viallon V; Arveux P; Kvaskoff M; Fournier A; Krogh V; Tumino R; Sánchez MJ; Ardanaz E; Chirlaque MD; Agudo A; Muller DC; Smith T; Tzoulaki I; Key TJ; Bueno-de-Mesquita B; Trichopoulou A; Bamia C; Orfanos P; Kaaks R; Hüsing A; Fortner RT; Zeleniuch-Jacquotte A; Sund M; Dahm CC; Overvad K; Aune D; Weiderpass E; Romieu I; Riboli E; Gunter MJ; Dossus L; Prentice R; Ferrari P
    Breast Cancer Res; 2018 Dec; 20(1):147. PubMed ID: 30509329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.